SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: Galirayo who wrote (14170)12/30/2005 10:51:54 AM
From: Jibacoa  Respond to of 23958
 
This news must be good for DOC ... it's up pre mk

Yes, I saw the announcement this morning and ADSX had a good upgap which hasn't been closed as yet in spite of the general market.

ADSX is getting ready for the IPO of VeriChip, which has already been marketing its VeriMed, which is used to identify people who arrive in an emergency room and are unable to communicate. It is the the first human-implantable RFID microchip which was given an OK by the FDA more than a year ago.

ADSX plans to retain 80% of the shares of VeriChip after the IPO.(The same it did with DOC.<g>)

DOC also started with an upgap and it traded at 3.25, but that gap has been closed and is now down $0.6 from yesterday's close,trying to hold above the $3 level.<g>



To: Galirayo who wrote (14170)12/30/2005 10:54:11 AM
From: Jibacoa  Read Replies (1) | Respond to of 23958
 
This news must be good for DOC ... it's up pre mk

Yes, I saw the announcement this morning and ADSX had a good upgap which hasn't been closed as yet in spite of the general market.

bigcharts.marketwatch.com

ADSX is getting ready for the IPO of VeriChip, which has already been marketing its VeriMed, which is used to identify people who arrive in an emergency room and are unable to communicate. It is the the first human-implantable RFID microchip which was given an OK by the FDA more than a year ago.

VeriMed has already been accepted in more than 65 hospitals

biz.yahoo.com

ADSX plans to retain 80% of the shares of VeriChip after the IPO.(The same it did with DOC.<g>)

The "consensus target"<g> for ADSX is around $5

finance.yahoo.com

bigcharts.marketwatch.com

DOC also started with an upgap and it traded at 3.25, but that gap has been closed and is now down $0.06 from yesterday's close,trying to hold above the $3 level.<g>

bigcharts.marketwatch.com

DOC has closed its Dec.16 upgap, but not its Nov.30 <g>

bigcharts.marketwatch.com

The "CT" for DOC is around $5.80 <g>

finance.yahoo.com

bigcharts.marketwatch.com